Table 2 Maternal and neonatal outcomes grouped by OGTT glucose levels.

From: The heterogeneous associations between gestational weight gain and adverse pregnancy outcomes in gestational diabetes mellitus according to abnormal glucose metabolism

 

Total (n = 2611)

OGTT groups

 

Outcomes

IFG (n = 234)

IGT (n = 1970)

IFG& IGT (n = 407)

P

PIH

233 (8.9)

20 (8.5)

149 (7.6)

64 (15.7)*,#

<0.001

Preterm delivery

323 (12.4)

26 (11.1)

223 (11.3)

74 (18.2)#

0.001

Cesarean delivery

1409 (54.0)

126 (53.8)

1027 (52.1)

256 (62.9)#

<0.001

Postpartum hemorrhage

99 (3.8)

14 (6.0)

67 (3.4)

18 (4.4)

0.144

Birth weight (g)

3259.9 ± 540.2

3311.9 ± 593.4

3233.5 ± 515.6

3357.7 ± 608.3#

<0.001

Macrosomia

174 (6.7)

19 (8.1)

102 (5.2)

53 (13.0)#

<0.001

Low body weight infants

192 (7.4)

20 (8.5)

141 (7.2)

31 (7.6)

0.725

LGA

595 (22.8)

61 (26.1)

401 (20.4)

133 (32.7)#

<0.001

SGA

102 (3.9)

8 (3.4)

85 (4.3)

9 (2.2)

0.126

  1. Data were expressed as mean ± SD or number (percentage). OGTT oral glucose tolerance test, IFG impaired fasting glucose group, IGT impaired glucose tolerance group, IFG&IGT both impaired group, PIH pregnancy-induced hypertension syndrome, LGA large for gestational age, SGA small for gestational age. *P < 0.017 vs IFG; #P < 0.017 vs IGT.